🦊/Investors

Panakes PartnersFull Portfolio

4 tracked investments · listed companies and verified rows first

Alesi Surgicalalesi-surgical.comin𝕏✓ verified

Alesi Surgical develops surgical products by combining product development expertise with commercial knowledge of surgical team needs.

HardwareHealthtechMedical DevicesCardiff, GB

Dominic Griffiths(CEO)in

Co-investorsMercia VenturesIW Capital

Corflowcorflow.comin𝕏✓ verified

Corflow develops diagnostic and therapeutic solutions to restore healthy microvascular blood flow in the human body, serving the cardiovascular medical device industry.

HardwareHealthtechMedical Devices

Martin(Physician Co-Founder)Rick Geoffrion(Chairman and CEO)

Co-investors415 CapitalBroadview VenturesLaerdal Million Lives FundKorysMérieux Equity Partners

Complement Therapeuticscomplementtx.comApr 2023

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsCambridge Innovation CapitalHadean VenturesSeroba Life SciencesBGVBioGeneration VenturesForbion+2 more

InnovHeartinnovheart.comJan 2022 · $55M

InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease.

HealthtechMedical Devices

David James Wilson(Chief Executive Officer)

Co-investorsCDP Venture CapitalIndaco Venture Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.